UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)-Reference-Cited by-同舟云学术

UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)

Published:2023-02 Issue:2 Volume:18 Page:169-180
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Bar Jair,Peled Nir,Schokrpur Shiruyeh,Wolner Mirjana,Rotem Ofer,Girard Nicolas,Aboubakar Nana Frank,Derijcke Sofie,Kian Waleed,Patel Sandip,Gantz-Sorotsky Hadas,Zer Alona,Moskovitz Mor,Metro Giulio,Rottenberg Yakir,Calles Antonio,Hochmair Maximilian,Cuppens Kristof,Decoster Lynn,Reck Martin,Limon Dror,Rodriguez Estelamari,Astaras Christoforos,Bettini Adrienne,Häfliger Simon,Addeo Alfredo

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference28 articles.

1. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non–small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

2. Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

3. Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer;Soria;N Engl J Med,2018

4. AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer;Cross;Cancer Discov,2014

5. Osimertinib or platinum–pemetrexed in EGFR T790M–positive lung cancer;Mok;N Engl J Med,2017

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world outcomes of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) treated with osimertinib (osi) vs. Afatinib or erlotinib;Lung Cancer;2024-09

2. Near-Complete Response to Osimertinib for Advanced Non-Small-Cell Lung Cancer in a Pretreated Patient Bearing Rare Compound Exon 20 Mutation (S768I + V774M): A Case Report;International Journal of Molecular Sciences;2024-07-09

3. Impact of CD151 overexpression on prognosis and therapy in non‐small cell lung cancer patients lacking EGFR mutations;Cell Proliferation;2024-07-09

4. Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review;Journal of Thoracic Oncology;2024-07

5. Investigation of age and smoking in NSCLC patients with uncommon EGFR mutations;Tuberk Toraks;2024-06-11